Rebound Growth Following Temporary Discontinuation of BRAFi and MEKi in a Patient With Multifocal BRAFV600E-Mutant Primary Brain Tumor.

Pisano A, Cupini S, Santonocito OS, Pollo B, Paterra R, Allegrini G, Finale C, Vannozzi F, Scudieri C, Montemurro VM, Anghileri E, Di Stefano AL.